About
Fulcrum Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
Apr 27 2026
Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors
Apr 20 2026
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
Mar 19 2026
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
Feb 24 2026
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Recent Videos

$FULC Fulcrum Therapeutics Q1 2026 Earnings | Why Pociredir Could Transform Sickle Cell Treatment
Apr 28, 2026

Fulcrum Therapeutics (FULC|$538.1M) - 2026 Q1 Earnings Analysis
Apr 27, 2026

Fulcrum Therapeutics Inc Naked Put
Apr 16, 2026

24_02_26 Noticias de acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI
Feb 24, 2026
Translate